보고서 요약(국문)

개요
전 세계 페닐에프린 염산염 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
페닐에프린 염산염은 페닐에프린의 염 형태로, 아드레날린 및 에페드린과 화학적으로 유사한 직접 작용성 교감신경흥분성 아민이며 강력한 혈관 수축 및 충혈 완화 효과를 나타냅니다. 페닐에프린은 시냅스 후 알파-아드레날린 수용체 작용제로서 혈관 수축, 수축기/이완기 혈압 증가, 반사성 서맥 및 심박출량 증가를 유발합니다. 특히 감기, 알레르기성 비염 및 부비동염 치료에 사용됩니다.
또한, 페닐에프린 염산염은 정제, 캡슐, 주사제, 비강 스프레이 및 점안액 형태로 제공됩니다. 염산페닐에프린은 감기나 알레르기 등으로 인한 코막힘을 완화하는 코막힘 완화제에 흔히 사용됩니다. 또한 부비동 충혈 및 압력 완화에도 사용됩니다. 증상을 완화시켜주지만 증상의 근본 원인을 치료하거나 회복 속도를 높여주지는 않습니다. 코와 부비동의 혈관 크기를 줄여 호흡을 편하게 해줍니다. 일부 안과 질환 치료에도 사용됩니다.
시장 동향: 성장 요인
코막힘 및 안과 질환 완화를 위한 사용 증가
코막힘 완화를 위한 사용 증가가 향후 시장 성장을 견인할 것으로 예상됩니다. 감기, 알레르기, 호흡기 감염 등 코막힘을 유발하는 질환의 발생률 증가는 염산페닐에프린에 대한 수요를 촉진하고, 이는 제품 사용 증가로 이어질 것입니다. 안과 질환, 특히 동공확대와 같은 안과 질환 완화를 위해 염산페닐에프린 스프레이가 널리 사용되고 있습니다.

예를 들어, 2023년 8월 3일, 동공확대용 마이드콤비(트로피카미드와 페닐에프린 염산염 점안 스프레이) 1%/2.5%를 상용화하는 안과 기술 회사인 아이노비아(Eyenovia, Inc.)는 마이드콤비의 첫 상업 판매를 승인받았습니다. 마이드콤비는 미국 식품의약국(FDA)의 승인을 받았습니다.
또한, 페닐에프린 염산염 제품은 일반의약품(OTC)으로 판매되고 있어 소비자들이 처방전 없이 코막힘을 자가 치료하려는 경향이 더 강해지고 있으며, 이는 제품 채택 증가에 기여할 수 있습니다. 편리한 비강 스프레이, 점안액, 점안 스프레이 또는 여러 증상을 해결하는 복합 제품과 같은 혁신적인 제형의 도입은 더 많은 소비자를 유인할 수 있습니다.
예를 들어, 2022년 11월 15일, 킨더 파마슈티컬 컴퍼니(Kinder Pharmaceutical Company)의 킨더팜스(KinderFarms)는 임상적으로 입증된 활성 성분은 사용했지만, 킨더만의 안전한 비활성 성분을 사용한 어린이용 의약품 라인인 킨더메드(KinderMed)를 출시했습니다. 이번 출시에는 어린이용 야간 감기 및 기침약(디펜히드라민 HCl, 페닐에프린 HCl)이 포함됩니다. KinderMed는 전국 19,000개 이상의 매장에서 판매를 시작했습니다.
또한, 이러한 제품 채택 증가로 인해 더욱 발전된 페닐에프린 염산염 제품 개발에 대한 관심이 높아지고 있습니다. 예를 들어, 2020년 6월 12일, Caplin Point Laboratories Limited는 미국 식품의약국(USFDA)으로부터 페닐에프린 염산염 주사제 USP 10mg/mL 단회 투여 바이알, 50mg/5mL(10mg/mL) 약국용 대량 포장, 100mg/10mL(10mg/mL) 약국용 대량 포장에 대한 약식 신약 허가 신청(ANDA)의 최종 승인을 받았습니다. 이는 VAZCULEP 주사제의 제네릭 치료 동등 버전(RLD)입니다.

또한, 알레르기, 안과 질환, 비강 질환 및 저혈압의 유병률 증가, FDA 승인 증가, 임상 시험 증가, 페닐에프린 염산염의 이점에 대한 인식 제고 및 제품 개발의 발전은 예측 기간 동안 시장 성장을 견인할 것으로 예상되는 요인입니다.
제약 요인
페닐에프린 염산염과 관련된 합병증 및 부작용(예: 가벼운 위장 장애, 수면 장애, 어지럼증, 현기증, 두통, 신경과민, 떨림, 빠른 심박수)과 손발의 혈류 감소 가능성은 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
글로벌 페닐에프린 염산염 시장은 유형, 적용 분야, 투여 경로, 유통 채널 및 지역별로 세분화됩니다.

(R)-(−)-페닐에프린 염산염 부문은 페닐에프린 염산염 시장 점유율의 약 48.5%를 차지했습니다.
(R)-(−)-페닐에프린 염산염 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. (R)-(−)-페닐에프린 염산염은 페닐에프린 및 α1-아드레날린 수용체 작용제로, 심실 근세포의 비대 성장을 촉진하고 여러 MAPK 신호 전달 경로를 활성화합니다. (R)-(−)-페닐에프린 염산염은 α1A-AR, α1D-AR 및 α1B-AR의 활성제입니다.
또한, (R)-(−)-페닐에프린 HCL은 알파-아드레날린 수용체에 대해 더 선택적인 것으로 알려져 있습니다. 이러한 선택성은 혈관 수축 및 코막힘 완화에 관여하는 특정 수용체를 표적화하는 효과를 향상시킬 수 있습니다. (R)-(−)-이성질체는 부작용이 적은 것으로 잘 알려져 있습니다. 이는 페닐에프린 염산염을 함유한 의약품을 사용하는 환자의 안전성을 높이는 데 기여할 수 있습니다.
또한, (R)-(−)-페닐에프린 염산염은 코막힘 완화를 위해 설계된 의약품 제형의 업계 표준으로 자리 잡았습니다. 이러한 장점으로 인해 채택이 증가함에 따라 (R)-(−)-페닐에프린 염산염에 대한 수요는 지속적으로 증가하고 있습니다.
지역 분석
북미는 시장 점유율의 약 39.6%를 차지했습니다.
북미 지역은 주요 업체와 선진 의료 시설의 강력한 입지로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 특히 미국은 주요 페닐에프린 염산염 제품 개발에 주력하는 제약 회사와 같은 주요 업체들의 본거지입니다.

예를 들어, 리테도스는 2021년 5월 21일 페닐에프린 염산염 주사제 0.8mg/10mL(80mcg/mL)와 페닐에프린 염산염 주사제 1mg/10mL(100mcg/mL) 두 가지 새로운 1회용 주사제를 출시했습니다. 이는 리테도스가 전국 병원 약국을 대상으로 6개월 동안 12개 제품을 순차적으로 출시하는 계획의 일환입니다.
또한, 약국, 진료소, 병원을 포함한 이 지역의 잘 구축된 의료 인프라는 이러한 제품의 유통과 접근성을 용이하게 합니다. 페닐에프린 염산염은 일반적으로 처방전 없이 구입할 수 있는 일반의약품(OTC)입니다. 소비자들이 처방전 없이 구매할 수 있다는 점은 OTC 제품의 시장 점유율을 높이는 데 기여할 수 있습니다.

경쟁 환경
페닐에프린 염산염 시장의 주요 글로벌 업체로는 Thermo Fisher Scientific Inc., Hikma Pharmaceuticals PLC, Fresenius Kabi USA, Pfizer Inc., FUJIFILM Wako Pure Chemical Corporation, Merck KGaA, Sagent Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Inc., Ralington Pharma LLP 및 GRIFFITH OVERSEAS PVT. LTD. 등이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 페닐에프린 염산염 시장에 상당한 영향을 미쳤습니다. 팬데믹 기간 동안 전 세계 의료 시스템은 COVID-19 환자 관리 및 치료에 집중했습니다. 이러한 우선순위 변화는 충혈 완화제와 같은 페닐에프린 염산염 제품을 포함한 특정 비필수 의약품에 대한 수요에 영향을 미쳤습니다. 팬데믹은 COVID-19 팬데믹에 대한 집중으로 인해 많은 임상 시험 및 연구 활동을 일시적으로 중단시켜 시장에 영향을 미쳤습니다. 또한 팬데믹은 이러한 제품의 전 세계적인 공급망에 차질을 초래했습니다.

시장 세분화
유형별
• (R)-(−)-페닐에프린 염산염
• L(-)-페닐에프린 염산염
• 기타
적용 분야별
• 호흡기 질환
• 안과 질환
• 알레르기 질환
• 기타
투여 경로별
• 경구
• 비강
• 정맥 주사
• 안과용
• 기타
유통 채널별
• 병원 약국
• 소매 약국
• 온라인 약국
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
보고서 구매 이유

• 유형, 적용 분야, 투여 경로, 유통 채널 및 지역별 글로벌 페닐에프린 염산염 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.
• 모든 세그먼트를 포함한 페닐에프린 염산염 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 페닐에프린 염산염 시장 보고서는 약 69개의 표, 70개의 그림, 189페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global phenylephrine hydrochloride market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
Phenylephrine hydrochloride is the salt form of phenylephrine, a direct-acting sympathomimetic amine chemically related to adrenaline and ephedrine with potent vasoconstrictor and decongestant properties. Phenylephrine is a post-synaptic alpha-adrenergic receptor agonist that causes vasoconstriction, increases systolic/diastolic pressures, reflex bradycardia, and stroke output. It is especially used for the treatment of colds, allergic rhinitis and sinusitis.
Moreover, phenylephrine hydrochloride is available in the form of tablets, capsules, injections, nasal sprays and eye drops. Phenylephrine hydrochloride is often used in nasal decongestant products to relieve congestion caused by conditions like the common cold or allergies. It is also used to relieve sinus congestion and pressure. It will relieve symptoms but will not treat the cause of the symptoms or speed recovery. It reduces the size of the blood vessels in the nose and sinuses helping to breathe more easily. It is also used to treat some eye disorders.
Market Dynamics: Drivers
Increasing adoption to alleviate nasal discomfort and eye disorders
The increasing adoption to alleviate nasal discomfort is expected to drive the market over the forecast period. The growing incidence of conditions that are leading to nasal discomforts, such as the common cold, allergies, or respiratory infections is expected to drive the demand for phenylephrine hydrochloride and this also leads to increasing adoption. Eye disorders are most common, and to get relief from eye disorders such as mydriasis, phenylephrine HCL sprays are commonly adopted.
For instance, on August 03, 2023, Eyenovia, Inc., an ophthalmic technology company commercializing Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for mydriasis, cleared the first commercial sale of Mydcombi. Mydcombi was approved by the US Food and Drug Administration.
Moreover, phenylephrine hydrochloride products are available over-the-counter (OTC), and consumers may be more inclined to self-treat nasal discomfort without the need for a prescription, contributing to increased adoption. The introduction of innovative formulations, such as convenient nasal sprays, eye drops and ophthalmic spray applications or combination products addressing multiple symptoms, may attract more consumers.
For instance, on November 15, 2022, KinderFarms, the Kinder Farmaceutical Company launched KinderMed, a line of clean children's medicines, made with clinically proven active ingredients, but clean, Kinder inactive ingredients. This launch includes Kids' Nighttime Cold and Cough (Diphenhydramine HCl, Phenylephrine HCl). KinderMed launched at over 19,000 stores nationwide.
In Addition, the increasing adoption leads to an increasing focus on developing more advanced phenylephrine hydrochloride products. For instance, on June 12, 2020, Caplin Point Laboratories Limited cleared the granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride injection USP, 10 mg/mL Single-Dose Vial, 50 mg/5 mL (10mg/mL) Pharmacy Bulk Package, and 100 mg/10 mL (10 mg/mL) Pharmacy Bulk Package, a generic therapeutic equivalent version of (RLD), VAZCULEP Injection.
Further, the increasing prevalence of allergic, ophthalmic, nasal disorders and hypotension, rising FDA approvals, increasing clinical trials, increasing awareness about the advantages of phenylephrine hydrochloride and advancements in the development of products are the factors expected to drive the market over the forecast period.
Restraints
Factors such as complications and side effects associated with the phenylephrine hydrochloride such as mild upset stomach, trouble sleeping, dizziness, lightheadedness, headache, nervousness, shaking, or fast heartbeat and this product may also reduce blood flow to hands or feet are expected to hamper the market.
Segment Analysis
The global phenylephrine hydrochloride market is segmented based on type, application, route of administration, distribution channel and region.
The (R)-(−)-phenylephrine hydrochloride segment accounted for approximately 48.5% of the phenylephrine hydrochloride market share
The (R)-(−)-phenylephrine hydrochloride segment is expected to hold the largest market share over the forecast period. (R)-(−)-Phenylephrine hydrochloride is a phenylephrine and an α1-adrenoceptor agonist that promotes hypertrophic growth in the ventricular myocytes and activates several MAPK signaling pathways. (R)-(−)-Phenylephrine hydrochloride is an activator of α1A-AR, α1D-AR and α1B-AR.
Moreover, (R)-(−)-Phenylephrine HCL is known to be more selective for alpha-adrenergic receptors. This selectivity can enhance its effectiveness in targeting specific receptors responsible for vasoconstriction and nasal decongestion. The (R)-(−)-enantiomer is very well known for its fewer side effects. This can contribute to a better safety profile for individuals using medications containing phenylephrine hydrochloride.
Additionally, (R)-(−)-Phenylephrine hydrochloride may have become an industry standard for pharmaceutical formulations designed to alleviate nasal congestion. With this increasing adoption due to their advantages, the demand for (R)-(−)-Phenylephrine hydrochloride is continuously increasing.
Geographical Analysis
North America accounted for approximately 39.6% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and advanced healthcare facilities. North America especially the United States is home to the presence of major players such as pharmaceutical companies which are focussing on developing the major phenylephrine hydrochloride products.
For instance, on May 21, 2021, Ritedose, launched two new unit dose syringe products, Phenylephrine Hydrochloride Injection 0.8 mg/10 mL (80 mcg/mL) and Phenylephrine Hydrochloride Injection 1 mg/10 mL (100 mcg/mL). These are part of a six-month, 12-product rollout from Ritedose for hospital pharmacies across the country.
Furthermore, the well-established healthcare infrastructure in the region, including pharmacies, clinics, and hospitals, facilitates the distribution and accessibility of these products. Phenylephrine hydrochloride is commonly available as an over-the-counter (OTC) medication. The accessibility of OTC products can contribute to a higher market share as consumers may purchase them without a prescription.
Competitive Landscape
The major global players in the phenylephrine hydrochloride market include Thermo Fisher Scientific Inc., Hikma Pharmaceuticals PLC, Fresenius Kabi USA, Pfizer Inc., FUJIFILM Wako Pure Chemical Corporation, Merck KGaA, Sagent Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Inc., Ralington Pharma LLP and GRIFFITH OVERSEAS PVT. LTD. among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global phenylephrine hydrochloride market. During the pandemic, healthcare systems globally focused on managing and treating COVID-19 cases. This shift in priorities impacted the demand for certain non-essential pharmaceuticals, including phenylephrine hydrochloride products like decongestants. The pandemic impacted the market by temporarily disrupting many clinical trials and research activities due to the redirected focus on the COVID-19 pandemic. The pandemic also disrupted the supply chain of these products globally.
Market Segmentation
By Type
• (R)-(−)-Phenylephrine Hydrochloride
• L(-)-Phenylephrine Hydrochloride
• Others
By Application
• Respiratory Disorders
• Ophthalmic Disorders
• Allergic Disorders
• Others
By Route of Administration
• Oral
• Nasal
• Intravenous
• Ophthalmic
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global phenylephrine hydrochloride market segmentation based on type, application, route of administration, distribution channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of phenylephrine hydrochloride market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global phenylephrine hydrochloride market report would provide approximately 69 tables, 70 figures, and 189 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by Route of Administration
3.4. Snippet by Distribution Channel
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption to Alleviate Nasal Discomfort and Eye Disorders
4.1.2. Restraints
4.1.2.1. Side Effects Associated with Phenylephrine Hydrochloride
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. Patent Analysis
5.8. Volume Analysis
5.9. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. (R)-(−)-Phenylephrine Hydrochloride*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. L(-)-Phenylephrine Hydrochloride
7.4. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Respiratory Disorders*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ophthalmic Disorders
8.4. Allergic Disorders
8.5. Others
9. By Route of Administration
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.1.2. Market Attractiveness Index, By Route of Administration
9.2. Oral*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Nasal
9.4. Intravenous
9.5. Ophthalmic
9.6. Others
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Hospital Pharmacies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Retail Pharmacies
10.4. Online Pharmacies
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Thermo Fisher Scientific Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Hikma Pharmaceuticals PLC
13.3. Fresenius Kabi USA
13.4. Pfizer Inc.
13.5. FUJIFILM Wako Pure Chemical Corporation
13.6. Merck KGaA
13.7. Sagent Pharmaceuticals, Inc.
13.8. Dr. Reddy’s Laboratories Inc.
13.9. Ralington Pharma LLP
13.10. GRIFFITH OVERSEAS PVT. LTD.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific Inc., 4.	Key Developments, Hikma Pharmaceuticals PLC, Fresenius Kabi USA, Pfizer Inc., FUJIFILM Wako Pure Chemical Corporation, Merck KGaA, Sagent Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Inc., Ralington Pharma LLP, GRIFFITH OVERSEAS PVT. LTD.

표 목록 (Tables)

List of Tables

Table 1 Global Phenylephrine Hydrochloride Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Phenylephrine Hydrochloride Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Phenylephrine Hydrochloride Market Value, By Route of Administration, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Phenylephrine Hydrochloride Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Phenylephrine Hydrochloride Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Phenylephrine Hydrochloride Market Value, By Type, 2021-2030 (US$ Million)

Table 8 Global Phenylephrine Hydrochloride Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Phenylephrine Hydrochloride Market Value, By Application, 2021-2030 (US$ Million)

Table 10 Global Phenylephrine Hydrochloride Market Value, By Route of Administration, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Phenylephrine Hydrochloride Market Value, By Route of Administration, 2021-2030 (US$ Million)

Table 12 Global Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 14 Global Phenylephrine Hydrochloride Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Phenylephrine Hydrochloride Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Phenylephrine Hydrochloride Market Value, By Type, 2021-2030 (US$ Million)

Table 17 North America Phenylephrine Hydrochloride Market Value, By Application, 2021-2030 (US$ Million)

Table 18 North America Phenylephrine Hydrochloride Market Value, By Route of Administration, 2021-2030 (US$ Million)

Table 19 North America Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 20 North America Phenylephrine Hydrochloride Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Phenylephrine Hydrochloride Market Value, By Type, 2021-2030 (US$ Million)

Table 22 South America Phenylephrine Hydrochloride Market Value, By Application, 2021-2030 (US$ Million)

Table 23 South America Phenylephrine Hydrochloride Market Value, By Route of Administration, 2021-2030 (US$ Million)

Table 24 South America Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 25 South America Phenylephrine Hydrochloride Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Phenylephrine Hydrochloride Market Value, By Type, 2021-2030 (US$ Million)

Table 27 Europe Phenylephrine Hydrochloride Market Value, By Application, 2021-2030 (US$ Million)

Table 28 Europe Phenylephrine Hydrochloride Market Value, By Route of Administration, 2021-2030 (US$ Million)

Table 29 Europe Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 30 Europe Phenylephrine Hydrochloride Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Phenylephrine Hydrochloride Market Value, By Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Phenylephrine Hydrochloride Market Value, By Application, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Phenylephrine Hydrochloride Market Value, By Route of Administration, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Phenylephrine Hydrochloride Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Phenylephrine Hydrochloride Market Value, By Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Phenylephrine Hydrochloride Market Value, By Application, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Phenylephrine Hydrochloride Market Value, By Route of Administration, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Phenylephrine Hydrochloride Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 40 Thermo Fisher Scientific Inc.: Overview

Table 41 Thermo Fisher Scientific Inc.: Product Portfolio

Table 42 Thermo Fisher Scientific Inc.: Key Developments

Table 43 Hikma Pharmaceuticals PLC: Overview

Table 44 Hikma Pharmaceuticals PLC: Product Portfolio

Table 45 Hikma Pharmaceuticals PLC: Key Developments

Table 46 Fresenius Kabi USA: Overview

Table 47 Fresenius Kabi USA: Product Portfolio

Table 48 Fresenius Kabi USA: Key Developments

Table 49 Pfizer Inc.: Overview

Table 50 Pfizer Inc.: Product Portfolio

Table 51 Pfizer Inc.: Key Developments

Table 52 FUJIFILM Wako Pure Chemical Corporation: Overview

Table 53 FUJIFILM Wako Pure Chemical Corporation: Product Portfolio

Table 54 FUJIFILM Wako Pure Chemical Corporation: Key Developments

Table 55 Merck KGaA: Overview

Table 56 Merck KGaA: Product Portfolio

Table 57 Merck KGaA: Key Developments

Table 58 Sagent Pharmaceuticals, Inc.: Overview

Table 59 Sagent Pharmaceuticals, Inc.: Product Portfolio

Table 60 Sagent Pharmaceuticals, Inc.: Key Developments

Table 61 Dr. Reddy’s Laboratories Inc.: Overview

Table 62 Dr. Reddy’s Laboratories Inc.: Product Portfolio

Table 63 Dr. Reddy’s Laboratories Inc.: Key Developments

Table 64 Ralington Pharma LLP: Overview

Table 65 Ralington Pharma LLP: Product Portfolio

Table 66 Ralington Pharma LLP: Key Developments

Table 67 GRIFFITH OVERSEAS PVT. LTD.: Overview

Table 68 GRIFFITH OVERSEAS PVT. LTD.: Product Portfolio

Table 69 GRIFFITH OVERSEAS PVT. LTD.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 2 Global Phenylephrine Hydrochloride Market Share, By Type, 2022 & 2030 (%)

Figure 3 Global Phenylephrine Hydrochloride Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Phenylephrine Hydrochloride Market Share, By Route of Administration, 2022 & 2030 (%)

Figure 5 Global Phenylephrine Hydrochloride Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 6 Global Phenylephrine Hydrochloride Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Phenylephrine Hydrochloride Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 8 (R)-(−)-Phenylephrine Hydrochloride Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 9 L(-)-Phenylephrine Hydrochloride Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 10 Others Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 11 Global Phenylephrine Hydrochloride Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 12 Respiratory Disorders Application in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 13 Ophthalmic Disorders Application in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 14 Allergic Disorders Application in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 15 Others Application in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 16 Global Phenylephrine Hydrochloride Market Y-o-Y Growth, By Route of Administration, 2022-2030 (%)

Figure 17 Oral Route of Administration in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 18 Nasal Route of Administration in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 19 Intravenous Route of Administration in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 20 Ophthalmic Route of Administration in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 21 Others Route of Administration in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 22 Global Phenylephrine Hydrochloride Market Y-o-Y Growth, By Distribution Channel, 2022-2030 (%)

Figure 23 Hospital Pharmacies Distribution Channel in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 24 Retail Pharmacies Distribution Channel in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 25 Online Pharmacies Distribution Channel in Global Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 26 Global Phenylephrine Hydrochloride Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 27 North America Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 28 Asia-Pacific Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 29 Europe Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 30 South America Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 31 Middle East and Africa Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 32 North America Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 33 North America Phenylephrine Hydrochloride Market Share, By Type, 2022 & 2030 (%)

Figure 34 North America Phenylephrine Hydrochloride Market Share, By Application, 2022 & 2030 (%)

Figure 35 North America Phenylephrine Hydrochloride Market Share, By Route of Administration, 2022 & 2030 (%)

Figure 36 North America Phenylephrine Hydrochloride Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 37 North America Phenylephrine Hydrochloride Market Share, By Country, 2022 & 2030 (%)

Figure 38 South America Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 39 South America Phenylephrine Hydrochloride Market Share, By Type, 2022 & 2030 (%)

Figure 40 South America Phenylephrine Hydrochloride Market Share, By Application, 2022 & 2030 (%)

Figure 41 South America Phenylephrine Hydrochloride Market Share, By Route of Administration, 2022 & 2030 (%)

Figure 42 South America Phenylephrine Hydrochloride Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 43 South America Phenylephrine Hydrochloride Market Share, By Country, 2022 & 2030 (%)

Figure 44 Europe Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 45 Europe Phenylephrine Hydrochloride Market Share, By Type, 2022 & 2030 (%)

Figure 46 Europe Phenylephrine Hydrochloride Market Share, By Application, 2022 & 2030 (%)

Figure 47 Europe Phenylephrine Hydrochloride Market Share, By Route of Administration, 2022 & 2030 (%)

Figure 48 Europe Phenylephrine Hydrochloride Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 49 Europe Phenylephrine Hydrochloride Market Share, By Country, 2022 & 2030 (%)

Figure 50 Asia-Pacific Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 51 Asia-Pacific Phenylephrine Hydrochloride Market Share, By Type, 2022 & 2030 (%)

Figure 52 Asia-Pacific Phenylephrine Hydrochloride Market Share, By Application, 2022 & 2030 (%)

Figure 53 Asia-Pacific Phenylephrine Hydrochloride Market Share, By Route of Administration, 2022 & 2030 (%)

Figure 54 Asia-Pacific Phenylephrine Hydrochloride Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 55 Asia-Pacific Phenylephrine Hydrochloride Market Share, By Country, 2022 & 2030 (%)

Figure 56 Middle East & Africa Phenylephrine Hydrochloride Market Value, 2021-2030 (US$ Million)

Figure 57 Middle East & Africa Phenylephrine Hydrochloride Market Share, By Type, 2022 & 2030 (%)

Figure 58 Middle East & Africa Phenylephrine Hydrochloride Market Share, By Application, 2022 & 2030 (%)

Figure 59 Middle East & Africa Phenylephrine Hydrochloride Market Share, By Route of Administration, 2022 & 2030 (%)

Figure 60 Middle East & Africa Phenylephrine Hydrochloride Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 61 Thermo Fisher Scientific Inc.: Financials

Figure 62 Hikma Pharmaceuticals PLC: Financials

Figure 63 Fresenius Kabi USA: Financials

Figure 64 Pfizer Inc.: Financials

Figure 65 FUJIFILM Wako Pure Chemical Corporation: Financials

Figure 66 Merck KGaA: Financials

Figure 67 Sagent Pharmaceuticals, Inc.: Financials

Figure 68 Dr. Reddy’s Laboratories Inc.: Financials

Figure 69 Ralington Pharma LLP: Financials

Figure 70 GRIFFITH OVERSEAS PVT. LTD.: Financials

세계 페닐에프린 염산염 시장 – 2023-2030

Global Phenylephrine Hydrochloride Market - 2023-2030